Vinblastine (Sulphate) Overview Categories 8 Antineoplastics, immunomodulators and drugs used in palliative care8.2 Cytotoxic (anti-neoplastic) drugs Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Vinblastine (Sulphate) Manufacturers of Vinblastine (Sulphate) Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Vinblastine (Sulphate)'s dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 100 ug/ sq.meter180 (183)As recommended.IVOnce in a Week Paedriatic Dosage (20kg) 2.5 to 6 mg/sq.meter4.2 (4.25)As recommended.Intra VenousOnce every 1-2 weeks for 3-6 Weeks Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Vinblastine (Sulphate) is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Vinblastine (Sulphate) Back to top Manufacturers of Vinblastine (Sulphate) in Pakistan Al-Habib Pharmedic Back to top Previous Drug Generic - Next Drug Generic